Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MMD's Seldane

Executive Summary

Suit filed in Miami federal court charges Ivax subsidiary Baker Norton with infringing MMD patent for carboxylic acid metabolite for the antihistamine terfenadine (Seldane). Baker Norton filed an ANDA for terfenadine on May 12. MMD previously had filed suit against Geneva over its ANDA for terfenadine. The basic Seldane patent expired April 15; the metabolite is patented until March 3, 1998
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel